Loading dashboard...
Peptide Assistant
Online
AI can make mistakes. Verify important medical data.
Press Enter to send
G
Medical Engine
Guest Account
AI can make mistakes. Verify important medical data.
Press Enter to send
Medical Engine
Guest Account
Loading dashboard...
The frontier of anabolic gene expression. Analyzing Myostatin Inhibition vs Follistatin upregulation.
YK-11 is technically a steroid derivative and requires Post-Cycle Therapy (PCT) due to potential suppression.
The "Belgian Blue" cattle breed represents the extreme end of myostatin inhibition. A natural genetic mutation results in a total loss of myostatin function, proving the anabolic potential of this pathway is theoretically limitless.
Follistatin efficacy is highly dependent on nitrogen balance. Ensure protein intake exceeds 2.5g/kg for optimal binding site utilization.
AAV (adeno-associated virus) gene therapy to permanently overexpress Follistatin is in early trials:
Current Status (2026): BioMarin gene therapy trials ongoing. Black market AAV vectors exist but EXTREMELY dangerous (permanent genetic modification).